Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Legend Biotech (LEGN) Return on Invested Capital (2020 - 2025)

Historic Return on Invested Capital for Legend Biotech (LEGN) over the last 6 years, with Q3 2025 value amounting to 133.2%.

  • Legend Biotech's Return on Invested Capital rose 949600.0% to 133.2% in Q3 2025 from the same period last year, while for Sep 2025 it was 133.2%, marking a year-over-year increase of 949600.0%. This contributed to the annual value of 105.19% for FY2024, which is 339400.0% down from last year.
  • Legend Biotech's Return on Invested Capital amounted to 133.2% in Q3 2025, which was up 949600.0% from 131.55% recorded in Q2 2025.
  • Legend Biotech's Return on Invested Capital's 5-year high stood at 133.2% during Q3 2025, with a 5-year trough of 48152.63% in Q2 2021.
  • Its 5-year average for Return on Invested Capital is 2981.55%, with a median of 16.55% in 2023.
  • Its Return on Invested Capital has fluctuated over the past 5 years, first plummeted by -222200bps in 2021, then soared by 949600bps in 2025.
  • Over the past 5 years, Legend Biotech's Return on Invested Capital (Quarter) stood at 21.29% in 2021, then soared by 102bps to 0.45% in 2022, then soared by 7209bps to 32.57% in 2023, then skyrocketed by 209bps to 100.79% in 2024, then skyrocketed by 32bps to 133.2% in 2025.
  • Its last three reported values are 133.2% in Q3 2025, 131.55% for Q2 2025, and 115.76% during Q1 2025.